Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer

This study is ongoing, but not recruiting participants.

Study NCT00390325 Information provided by National Cancer Institute (NCI)

First Received: October 18, 2006 Last Updated: May 25, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	February 2008 (Final data collection date for primary outcome measure)

Publications: